Merck & Co Inc (CHIX:6MKd) Stock News, Headlines & Updates
Merck & Co Inc Stock News from GuruFocus
- 1
Jul 01, 2024
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
Business Wire • 6:00am
Jun 28, 2024
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
Business Wire • 6:00am
CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
Business Wire • 8:00pm
Jun 27, 2024
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
Business Wire • 7:00pm
Jun 25, 2024
USDA Approves Merck Animal Health's NOBIVAC® NXT Canine Flu H3N2 -- The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Business Wire • 4:00pm
Jun 20, 2024
Merck Is Partnering With America's Largest HBCU To Launch a Collaborative Biotechnology Learning Center
ACCESSWIRE • 11:00am
Jun 17, 2024
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
Business Wire • 5:00pm
Merck & Co Inc's Dividend Analysis
GuruFocus Research • 5:01am
Jun 12, 2024
Women in Science? At Merck, Absolutely
ACCESSWIRE • 3:00pm
Jun 07, 2024
How Merck Scientists Are Driving Next-Generation Cancer Research
ACCESSWIRE • 11:00am
Jun 06, 2024
How Merck Scientists Are Driving Next-Generation Cancer Research
ACCESSWIRE • 11:00am
Jun 05, 2024
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 6:00am
May 29, 2024
Merck to Acquire EyeBio
Business Wire • 6:00am
May 28, 2024
Merck Announces Third-Quarter 2024 Dividend
Business Wire • 3:00pm
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus Research • 9:32am
May 08, 2024
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers
ACCESSWIRE • 11:00am
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
Business Wire • 6:00am
Apr 29, 2024
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Business Wire • 9:00am
Apr 26, 2024
Q1 2024 Merck & Co Inc Earnings Call Transcript
GuruFocus Research • 11:16pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news